Mirati Therapeutics, Inc.
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinic…
Biotechnology
US, San Diego [HQ]
Ratios
14 Sheets · From 2022 to 2009Configuration
Margins, Growth Rates In %
| Ratio | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||
| Gross Margin | 100.00 | 100.00 | 100.00 | 100.00 | - - | - - | - - | - - | - - | -626.23 | -5,383.24 | -2,134.28 | -605.48 | 95.18 | |
| Profit Margin | -781.13 | -614.94 | -314.59 | -1,012,700.00 | - - | - - | - - | - - | - - | -761.40 | -6,374.72 | -2,667.76 | -807.00 | -5,957.44 | |
| Operating Margin | -782.32 | -615.78 | -323.06 | -1,022,150.00 | - - | - - | - - | - - | - - | -793.96 | -6,659.79 | -2,756.85 | -795.07 | -6,107.98 | |
|
EPS Growth
|
-198.61 | 39.51 | 91.75 | -36.00 | -134.31 | 32.22 | -17.90 | -9.95 | 33.57 | -14.34 | -77.74 | -40.04 | -41.18 | -17.57 | |
| EPS USD | -3,004.00 | -1,817.00 | -150.00 | -204.00 | -478.00 | -324.00 | -382.00 | -420.00 | -279.00 | -319.00 | -567.00 | -794.00 | -1,121.00 | -1,318.00 | |
| Return on Assets (ROA) | -107.22 | -134.64 | -30.77 | -51.15 | -81.93 | -130.48 | -50.39 | -131.05 | -44.82 | -43.08 | -49.19 | -24.21 | -36.62 | -61.60 | |
| Return on Equity (ROE) | -188.70 | -361.85 | -35.03 | -59.15 | -204.26 | -155.67 | -54.59 | -172.11 | -49.19 | -48.82 | -55.61 | -26.27 | -41.64 | -74.35 | |
| Return on Invested Capital (ROIC) | -181.70 | -330.53 | - - | -59.82 | -123.44 | -139.73 | -54.55 | -173.10 | -49.83 | -58.06 | -66.25 | -26.29 | -39.91 | -72.53 | |
| Solvency | |||||||||||||||
| Equity Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Debt/Assets | 2.62 | 3.59 | - - | - - | - - | - - | - - | - - | - - | -7.55 | -11.13 | 2.84 | 2.97 | 4.28 | |
| Debt/Equity | 4.61 | 9.66 | - - | - - | - - | - - | - - | - - | - - | -8.56 | -12.58 | 3.08 | 3.38 | 5.17 | |
| Debt/EBITDA | 60.76 | 49.95 | 102.60 | 91.32 | 165.02 | 76.24 | 189.03 | 67.72 | 210.86 | 217.09 | 186.87 | 365.01 | 64.06 | 24.19 | |
|
Debt/Capitalization
|
4.40 | 8.81 | - - | - - | - - | - - | - - | - - | - - | -9.35 | -14.39 | 2.99 | 3.27 | 4.91 | |
| Long-Term Debt/Capitalization | 2.95 | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 2.99 | 3.18 | 4.20 | |
| Interest Debt per Share USD | 0.76 | 0.52 | - - | - - | 0.02 | - - | - - | - - | - - | -0.56 | -1.28 | 0.93 | 0.91 | 0.60 | |
| Debt Growth | 13.28 | -28.75 | -100.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | 9.48 | 12.26 | |
| Liquidity | |||||||||||||||
| Current Ratio | 310.17 | 191.16 | 812.59 | 736.60 | 166.14 | 605.21 | 1,279.87 | 396.98 | 1,141.59 | 866.90 | 867.80 | 1,963.91 | 1,049.70 | 695.50 | |
| Quick Ratio | 303.17 | 173.64 | 763.43 | 716.36 | 164.21 | 980.69 | 1,994.26 | 608.37 | 1,423.39 | 1,582.09 | 1,605.39 | 2,654.12 | 1,039.87 | 680.29 | |
| Cash Ratio | 215.60 | 144.90 | 263.64 | 344.67 | 36.83 | 543.05 | 1,248.49 | 378.18 | 1,105.52 | 852.10 | 848.67 | 1,944.97 | 287.55 | 147.55 | |
| Operating Cash Flow Ratio | -300 | -300 | -300 | -300 | - - | -600 | -500 | -400 | -400 | -200 | -300 | -300 | -200 | -300 | |
| Turnover | |||||||||||||||
| Inventory Turnover | - - | - - | - - | - - | - - | - - | - - | -37,424.59 | -24,508.44 | -12,222.92 | -11,677.27 | -12,992.58 | -20,238.52 | 19.87 | |
| Receivables Turnover | 158.20 | 163.63 | 1,777.01 | 0.16 | - - | - - | - - | - - | - - | 1,683.07 | 212.96 | 581.51 | 2,868.76 | 1,437.69 | |
| Payables Turnover | - - | - - | - - | - - | - - | - - | - - | 456.52 | 425.72 | 364.20 | 380.32 | 1,652.31 | 1,446.39 | 1.54 | |
|
Asset Turnover
|
13.73 | 21.90 | 9.78 | 0.01 | - - | - - | - - | - - | - - | 5.66 | 0.77 | 0.91 | 4.54 | 1.03 | |
| Fixed Turnover | 257.46 | 555.58 | 1,386.55 | 0.60 | - - | - - | - - | - - | - - | 2,732.77 | 187.78 | 28.09 | 134.74 | 23.17 | |
| Coverage | |||||||||||||||
| Interest Coverage | -112,506.96 | -47,454.90 | -35,675.12 | -65,945.38 | -15,746.80 | - - | - - | - - | - - | - - | - - | - - | - - | 4,229.57 | |
| Asset Coverage | 2,700 | 1,500 | - - | - - | - - | - - | - - | - - | - - | - - | - - | 3,300 | 3,100 | 2,000 | |
| Cash Flow Coverage (CFGR) | -3,718.75 | -4,008.93 | - - | - - | - - | - - | - - | - - | - - | 406.50 | 307.24 | -647.97 | -823.38 | -1,107.80 | |
| EBITDA Coverage | -106,800 | -45,000 | -34,900 | -64,600 | -4,200 | - - | - - | - - | - - | - - | - - | - - | - - | 4,200 | |
| Dividend Coverage | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Time Interest Earned (TIE) | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Market Prospects | |||||||||||||||
| Dividend Yield | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Earnings Yield | -426.17 | -257.74 | -21.25 | -29.00 | -28.75 | -17.49 | -12.08 | -88.46 | -15.27 | -7.51 | -4.40 | -3.62 | -7.64 | -29.08 | |
|
Price/Earnings (P/E)
|
-23.46 | -38.80 | -470.52 | -344.82 | -347.78 | -571.62 | -827.97 | -113.04 | -654.82 | -1,331.75 | -2,270.99 | -2,764.51 | -1,308.16 | -343.91 | |
| Price/Earnings Growth (PEG) | -0.12 | 0.98 | 5.13 | -9.58 | -2.59 | 17.74 | -46.25 | -11.36 | 19.51 | -92.89 | -29.21 | -69.05 | -31.76 | -19.57 | |
|
Price/Book (P/B)
|
44.28 | 140.39 | 164.81 | 203.96 | 710.37 | 889.83 | 451.95 | 194.56 | 322.11 | 650.22 | 1,262.92 | 726.13 | 544.77 | 255.68 | |
| Price/Tangible Book (P/TB) | 44.28 | 140.39 | 164.81 | 203.96 | 710.37 | 889.83 | 451.95 | 194.56 | 322.11 | 650.22 | 1,262.92 | 726.13 | 544.77 | 255.68 | |
| Price/Sales (P/S) | 183.29 | 238.59 | 1,480.18 | 3,491,955.76 | - - | - - | - - | - - | - - | 10,139.88 | 144,769.52 | 73,750.32 | 10,556.86 | 20,487.96 | |
|
Price/Cash Flow (P/CF)
|
-25.84 | -36.27 | -397.91 | -413.32 | -624.27 | -762.51 | -1,053.16 | -138.18 | -713.29 | -1,869.84 | -3,268.26 | -3,639.02 | -1,957.47 | -446.55 | |
| Price/Free CF (P/FCF) | -25.78 | -36.25 | -394.17 | -407.77 | -619.98 | -753.62 | -1,046.37 | -137.79 | -712.40 | -1,866.59 | -3,234.28 | -3,581.42 | -1,909.37 | -442.79 | |
| Price/Operating CF (P/OCF) | -25.84 | -36.27 | -397.91 | -413.32 | -624.27 | -762.51 | -1,053.16 | -138.18 | -713.29 | -1,869.84 | -3,268.26 | -3,639.02 | -1,957.47 | -446.55 |